Article Details

Strides Pharma arm appoints Mark W Womack as new CEO

Retrieved on: 2021-08-06 08:48:45

Tags for this article:

Click the tags to see associated articles and topics

Strides Pharma arm appoints Mark W Womack as new CEO. View article details on hiswai:

Excerpt

Bengaluru: Stelis Biopharma Limited, biotech arm of Strides Pharma Science Limited, has recently announced the appointment of Mark W. Womack as ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up